| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/1996 | WO1996011700A1 Reduction of mammalian neoplasms with phospholipase a2 activatiing substances |
| 04/25/1996 | WO1996011699A1 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| 04/25/1996 | WO1996011698A1 Allosteric modulators of the nmda receptor |
| 04/25/1996 | WO1996011697A1 Thrombin inhibitors |
| 04/25/1996 | WO1996011696A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | WO1996011695A1 Low molecular weight growth potentiating peptides |
| 04/25/1996 | WO1996011689A1 Use of cck-b receptor antagonists for the treatment of sleep disorders |
| 04/25/1996 | WO1996011664A2 Nsk2 a muscle receptor tyrosine kinase |
| 04/25/1996 | WO1996011584A1 Peptide mixture and products thereof |
| 04/25/1996 | WO1996011562A2 Human checkpoint gene and gene for antisense rna thereof |
| 04/25/1996 | WO1995031541A3 Methods and compositions for treatment of restenosis and cancer using ribozymes |
| 04/25/1996 | DE4437868A1 Behandlung von HLA-DR-assoziierter Immundefizienz mit Interferon-gamma Treatment of HLA-DR-associated immunodeficiency with interferon-gamma |
| 04/25/1996 | DE4437604A1 Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung Conjugates of a poly- or oligopeptide and a low molecular weight lipophilic compound |
| 04/25/1996 | CA2472085A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | CA2203116A1 Hemoglobin receptors from neisseriae |
| 04/25/1996 | CA2202628A1 Apoptosis-associated gene |
| 04/25/1996 | CA2202622A1 Use of protease inhibitors and protease vaccines to protect animals from flea infestation, and flea protease proteins, nucleic acid molecules and uses thereof |
| 04/25/1996 | CA2202612A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 04/25/1996 | CA2202533A1 Her4 human receptor tyrosine kinase |
| 04/25/1996 | CA2202478A1 Cell-specific gene delivery vehicles |
| 04/25/1996 | CA2202465A1 Process for the diagnostic assessment and monitoring, as well as medicaments for the therapy of states of shock in humans |
| 04/25/1996 | CA2202379A1 Dipeptide derivatives, process for their production and pharmaceutical agents containing these compounds |
| 04/25/1996 | CA2202283A1 Polycystic kidney disease gene |
| 04/25/1996 | CA2202048A1 Screening assay for anti-hiv drugs |
| 04/25/1996 | CA2201479A1 New peptides with immunomodulatory effects |
| 04/24/1996 | EP0708179A2 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/24/1996 | EP0708178A1 Survival motor neuron (SMN) gene: a gene for spinal muscular atrophy |
| 04/24/1996 | EP0708085A2 Antiviral ethers of aspartate protease substrate isosteres |
| 04/24/1996 | EP0707855A2 Combination therapy for chronic hepatitis C infection |
| 04/24/1996 | EP0707854A2 Compositions for the treatment of gastronitestinal disorders containing bismuth and an antimicrobial |
| 04/24/1996 | EP0707653A1 Method for specific silencing of genes by dna methylation |
| 04/24/1996 | EP0707652A1 Dna coding for a peptide of a papilloma virus main capside protein and use thereof |
| 04/24/1996 | EP0707649A1 Cisplatin resistance gene and uses therefor |
| 04/24/1996 | EP0707648A1 Platelet glycoprotein v gene and uses |
| 04/24/1996 | EP0707644A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 04/24/1996 | EP0707638A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/24/1996 | EP0707598A1 Human spasmolytic polypeptide in glycosylated form |
| 04/24/1996 | EP0707596A1 Conjugation-stabilized polypeptide compositions |
| 04/24/1996 | EP0707595A1 Peptidase resistant thrombin receptor peptide ligand |
| 04/24/1996 | EP0707496A1 METHODS AND COMPOSITIONS FOR DETECTING AND TREATING MYCOBACTERIAL INFECTIONS USING AN inhA GENE |
| 04/24/1996 | EP0707493A1 Inhibitors and target molecule co-localization |
| 04/24/1996 | EP0707492A1 H 2? antagonist-gastrointestinal motility agent combinations |
| 04/24/1996 | EP0707491A1 Use of human growth hormone for preoperative administration |
| 04/24/1996 | EP0707490A1 Neuropeptide y antagonists and agonists |
| 04/24/1996 | EP0707489A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 04/24/1996 | EP0707488A1 Cyclohexapeptidyl amine compounds |
| 04/24/1996 | EP0707487A1 Methods and pharmaceutical compositions useful for treating neurological disorders |
| 04/24/1996 | EP0707485A1 Anti-cholesterolemic egg, vaccine and method for production, and use |
| 04/24/1996 | EP0707446A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 04/24/1996 | EP0625194B1 Enhancement of ribozyme catalytic activity by a neighboring facilitator oligonucleotide |
| 04/24/1996 | EP0489070B1 Novel inhibitors of thrombin |
| 04/24/1996 | EP0380542B1 Method for treating malignancy and autoimmune disorders in humans |
| 04/24/1996 | CN1121355A Variants of bile salt-stimulated lipase, DNA molecules encoding them, and transgenic non-human mammals |
| 04/24/1996 | CN1121311A Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 04/24/1996 | CN1121077A New peptide compounds derived from boronic acid, process for preparing them and pharmaceutical compositions containing them |
| 04/24/1996 | CN1121068A Prolineamide derivatives |
| 04/23/1996 | US5510531 Antiinflammatroy agents, muscular disorders |
| 04/23/1996 | US5510487 Retroviral protease inhibitors |
| 04/23/1996 | US5510472 Production of recombinant human interferon-beta2 |
| 04/23/1996 | US5510466 Scavenger receptor protein and antibody thereto |
| 04/23/1996 | US5510465 Generating non-specific complement activation in reduced amount in an in vitro assay while being capable of retaining antigen binding and specific complement activating activity |
| 04/23/1996 | US5510464 Administration of low dose hemoglobin to increase perfusion |
| 04/23/1996 | US5510462 IL-1βprotein precursor |
| 04/23/1996 | US5510461 pp: A newly identified CD45-associated protein |
| 04/23/1996 | US5510458 CRF antagonists |
| 04/23/1996 | US5510418 Glycosaminoglycan-synthetic polymer conjugates |
| 04/23/1996 | US5510378 Retroviral protease inhibitors |
| 04/23/1996 | US5510370 Osteoporosis, osteoarthritis treatment |
| 04/23/1996 | US5510369 Pyrrolidine thrombin inhibitors |
| 04/23/1996 | US5510349 Retroviral protease inhibitors |
| 04/23/1996 | US5510341 Ovulation-inhibiting preparation for hormonal contraception |
| 04/23/1996 | US5510333 Inhibitors of Cathepsin G and elastase for preventing connective tissue degradation |
| 04/23/1996 | US5510332 Peptide of from 4 to 13 amino acid residues |
| 04/23/1996 | US5510331 Antihypertensive peptides |
| 04/23/1996 | US5510330 Combinations of thrombolytically active proteins and non-heparin anticoagulants, and uses thereof. |
| 04/23/1996 | US5510329 Inducing corneal regeneration of endothelium by injection of fibroblast growth factor in carrier |
| 04/23/1996 | US5510328 Compositions that inhibit wound contraction and methods of using same |
| 04/23/1996 | US5510327 Containing tumor cytotoxic factor, basic amino acid or salt thereof, organic or inorganic salt |
| 04/23/1996 | US5510264 Antibodies which bind meningitis related homologous antigenic sequences |
| 04/23/1996 | US5510259 Isolated, purified dna having nucleotide sequence coding for said molecule |
| 04/23/1996 | US5510256 Genetically engineered dna sequences which do not code for a lymphocyte membrane polypeptide |
| 04/23/1996 | US5510248 Isolated polynucleotide encoding anticoagulant polypeptide having amino acid sequence of prothrombin with amino acid substitutions at residues 155, 271, 284 |
| 04/23/1996 | US5510240 Method of screening a peptide library |
| 04/23/1996 | US5510239 One of the intersugar linkages between nuclotide units of the oligonuclotide is phosphorothioate linkage |
| 04/23/1996 | US5510121 Containing a synthetic hydrophilic polymer |
| 04/23/1996 | US5510105 Lysing unwanted non-malignant cells(lymphocytes)involved in transplant rejection in a mammal |
| 04/23/1996 | US5510104 Administering a selective alpha-amino acids or their alkyl esters in presence of halide; microbiocides; myeloperoxidase, eosinophil peroxidase |
| 04/23/1996 | US5510102 Plasma and polymer containing surgical hemostatic adhesives |
| 04/23/1996 | CA1338262C Antitumor antibiotic kedarcidin |
| 04/23/1996 | CA1338260C Human protein s, a plasma protein regulator of hemostasis |
| 04/21/1996 | CA2160975A1 Use of vwf-containing concentrates as a therapy which is employed in combination with antithrombotic and fibrinolytic therapy |
| 04/20/1996 | CA2160763A1 Antiviral ethers of aspartate protease substrate isosteres |
| 04/19/1996 | CA2160753A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 04/18/1996 | WO1996011278A1 Immortalized lines of endothelial brain cells and therapeutical applications thereof |
| 04/18/1996 | WO1996011277A1 Microorganisms as therapeutic delivery systems |
| 04/18/1996 | WO1996011276A1 Method, reagent and kit for evaluating susceptibility to premature atherosclerosis and treatment of same using gene therapy |
| 04/18/1996 | WO1996011272A2 Papilloma virus-like particles, fusion proteins and process for producing the same |
| 04/18/1996 | WO1996011271A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/18/1996 | WO1996011270A1 Cloning and characterizing of genes associated with long-term memory |
| 04/18/1996 | WO1996011269A2 Tie-2 ligands, methods of making and uses thereof |